The effect of a dual-wavelength 532 nm and 1064 nm picosecond-domain laser with a fractionated holographic optic on photoaging and patient age perception: A pilot study.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Jan 2022
Historique:
revised: 25 10 2021
received: 19 07 2021
accepted: 12 11 2021
pubmed: 16 12 2021
medline: 29 12 2021
entrez: 15 12 2021
Statut: ppublish

Résumé

This study evaluated the efficacy of a dual-wavelength 532 nm/1064 nm Nd:YAG picosecond-domain laser with a holographic lens array in treating facial photoaging. Thirteen subjects were enrolled with 10 completing the study. Receiving three-month treatments, subjects underwent full-face spot treatment of facial lentigines with the 532-nm non-fractionated handpiece, followed by two sequential facial passes of the 1064-nm and the 532-nm fractionated handpieces. Improvement was measured by treating physician evaluation of pigmentation and rhytids as well as blinded reviewer evaluation of pre- and post-treatment image sets taken 12 weeks after the final treatment. Participants completed treatment surveys to assess satisfaction. Physician grading on a 5-point scale revealed an average improvement of 1.6 in pigmentation (p = 0.0042) and 0.9 in rhytids (p = 0.0196). Blinded physicians appropriately selected baseline images in 44 of 50 (88%) image sets (10 subjects; five reviewers). On an 11-point scale for overall facial photoaging (0 = no change, 1 = 10% improvement, 2 = 20% improvement, etc.) treating physicians scored mean improvement as 3.3 ± 1.83 (95% CI 1.99 to 4.61; range 1-6), while blinded reviewers scored mean improvement as 2.32 ± 2.62 (range % -4 to 8, 95% CI 1.57 to 3.07). The greatest majority (80%) of participants reported satisfaction with the treatment. Adverse events were mild; however, one patient developed hyperpigmentation, consistent with melasma that was successfully treated with topical agents. This is the first study to show that picosecond-domain 532 nm/1064 nm laser treatments with combination non-fractionated and fractionated handpieces are well-tolerated, safe, and effective for the treatment of photodamage.

Identifiants

pubmed: 34908229
doi: 10.1111/jocd.14654
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

320-326

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Ge Y, Guo L, Wu Q, Zhang M, Zeng R, Lin T. A prospective split-face study of the picosecond alexandrite laser with specialized lens array for facial photoaging in Chinese. J Drugs Dermatol. 2016;15(11):1390-1396.
Poon F, Kang S, Chien AL. Mechanisms and treatments of photoaging. Photodermatol Photoimmunol Photomed. 2015;31(2):65-74.
Bernstein EF, Bhawalkar J, Schomacker KT. A novel titanium sapphire picosecond-domain laser safely and effectively removes purple, blue, and green tattoo inks. Lasers Surg Med. 2018;50(7):704-710.
Brauer JA, Reddy KK, Anolik R, et al. Successful and rapid treatment of blue and green tattoo pigment with a novel picosecond laser. Arch Dermatol. 2012;148(7):820-823.
Herd RM, Alora MB, Smoller B, Arndt KA, Dover JS. A clinical and histologic prospective controlled comparative study of the picosecond titanium:sapphire (795 nm) laser versus the Q-switched alexandrite (752 nm) laser for removing tattoo pigment. J Am Acad Dermatol. 1999;40(4):603-606.
Kauvar ANB, Keaney TC, Alster T. Laser treatment of professional tattoos with a 1064/532-nm dual-wavelength picosecond laser. Dermatol Surg. 2017;43(12):1434-1440.
Ross V, Naseef G, Lin G, et al. Comparison of responses of tattoos to picosecond and nanosecond Q-switched neodymium: YAG lasers. Arch Dermatol. 1998;134(2):167-171.
Bernstein EF, Schomacker KT, Basilavecchio LD, Plugis JM, Bhawalkar JD. Treatment of acne scarring with a novel fractionated, dual-wavelength, picosecond-domain laser incorporating a novel holographic beam-splitter. Lasers Surg Med. 2017;49(9):796-802.
Bernstein EF, Schomacker KT, Paranjape AS, Bhawalkar JD. Treatment of photoaging with a dual-wavelength, 532 nm and 1,064 nm picosecond-domain laser producing a fractionated treatment beam using a holographic optic. J Drugs Dermatol. 2017;16(11):1077-1082.
Brauer JA, Kazlouskaya V, Alabdulrazzaq H, et al. Use of a picosecond pulse duration laser with specialized optic for treatment of facial acne scarring. JAMA Dermatol. 2015;151(3):278-284.
Gold MH, Sensing W, Biron J. Fractional Q-switched 1,064-nm laser for the treatment of photoaged-photodamaged skin. J Cosmetic Laser Ther. 2014;16(2):69-76.
Haimovic A, Brauer JA, Cindy Bae YS, Geronemus RG. Safety of a picosecond laser with diffractive lens array (DLA) in the treatment of Fitzpatrick skin types IV to VI: a retrospective review. J Am Acad Dermatol. 2016;74(5):931-936.
Khetarpal S, Desai S, Kruter L, et al. Picosecond laser with specialized optic for facial rejuvenation using a compressed treatment interval. Lasers Surg Med. 2016;48(8):723-726.
Wat H, Yee-Nam Shek S, Yeung CK, Chan HH. Efficacy and safety of picosecond 755-nm alexandrite laser with diffractive lens array for non-ablative rejuvenation in Chinese skin. Lasers Surg Med. 2019;51(1):8-13.
Weiss RA, McDaniel DH, Weiss MA, Mahoney AM, Beasley KL, Halvorson CR. Safety and efficacy of a novel diffractive lens array using a picosecond 755 nm alexandrite laser for treatment of wrinkles. Lasers Surg Med. 2017;49(1):40-44.
Wu DC, Fletcher L, Guiha I, Goldman MP. Evaluation of the safety and efficacy of the picosecond alexandrite laser with specialized lens array for treatment of the photoaging decolletage. Lasers Surg Med. 2016;48(2):188-192.
Anderson R, Parrish J. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science. 1983;220(4596):524-527.
Wu DC, Jones IT, Boen M, Al-Haddad M, Goldman MP. A randomized, split-face, double-blind comparison trial between fractionated frequency-doubled 1064/532 nm picosecond Nd:YAG laser and fractionated 1927 nm thulium fiber laser for facial photorejuvenation. Lasers Surg Med. 2021;53(2):204-211.
Serra M, Bohnert K, Sadick N. A randomized, single-blind, study evaluating a 755-nm picosecond pulsed Alexandrite laser vs. a non-ablative 1927-nm fractionated thulium laser for the treatment of facial photopigmentation and aging. J Cosmet Laser Ther. 2018;20(6):335-340.
Gold MH. Dual wavelength treatment protocol with a picosecond laser for the reduction of facial wrinkles. J Cosmet Laser Ther. 2019;21(3):147-151.
Lyons AB, Moy RL, Herrmann JL. A randomized, controlled, split-face study of the efficacy of a picosecond laser in the treatment of melasma. J Drugs Dermatol. 2019;18(11):1104-1107.

Auteurs

Hayley Leight-Dunn (H)

UnionDerm, New York, New York, USA.

Ali Hadi (A)

Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Forum Patel (F)

UnionDerm, New York, New York, USA.

Christopher J Yao (CJ)

School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA.

Yingqi Michelle Tu (YM)

UnionDerm, New York, New York, USA.

Anne Chapas (A)

UnionDerm, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH